|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00876 KAISA HEALTH
Nominal 
0.027 +0.003 (+12.500%) | 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 88,516 | -4.400% | 185,882 | 191,499 | 209,626 | 183,810 |
| Cost of Sales | (50,664) | -6.230% | (104,809) | (108,934) | (112,211) | (93,847) |
| Gross Profit | 37,852 | -1.836% | 81,073 | 82,565 | 97,415 | 89,963 |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | (64,129) | -- | -- | |
| Change in FV & Impairment on Others | (11,489) | -57.993% | (25,310) | (41,237) | 57,950 | (6,019) | |
| Profit / (Loss) on Disposal | -- | -- | 69,391 | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (22,620) | -- | 6,046 | (170,963) | 11,203 | (41,473) | |
| Taxation | (1,644) | 30.269% | 104 | (1,169) | (23,526) | 778 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 1,318 | 48,814 | 14,682 | 1,003 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (24,264) | -- | 7,468 | (123,318) | 2,359 | (39,692) | |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | (681) | -- | 594 | 4,725 | 6,864 | 440 |
| Depreciation & Amortisation | 7,721 | -29.165% | 17,887 | 31,312 | 27,390 | 20,520 |
| Directors' Emoluments | -- | -- | 18,105 | 23,123 | 20,446 | 25,154 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -0.480 | -- | 0.150 | -2.450 | 0.050 | -0.790 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.007) | (0.012) | (0.024) | (0.006) |
| NBV per share ($) | 0.091 | -- | 0.098 | 0.096 | 0.129 | 0.126 |
| Remarks: | Real time quote last updated: 05/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -24,264,000 |
| %Change | -- |
| EPS / (LPS) | HKD -0.005 |
| NBV Per Share ($) | HKD 0.091 |